Bibliography
- WEIDNER N et al.: Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl. J. Med. (1991) 324:1–8.
- FOLKMAN J: Ann. Surg. (1972) 175:409–416.
- FOLKMAN J, SHING Y: Angiogenesis. J. Biol. Chem. (1992) 267:10931–10934.
- MUKHOPADHYAY D et al.: The von Hippel-Lindau tu-mor suppressor gene product interacts with Spl to re-press vascular endothelial growth factor promoter activity. Mol. Cell Biol. (1997) 17(9):5629–5639.
- CHENG SY et al.: Suppression of glioblastoma angio-genicity and tumorigenicity by inhibition of endoge-nous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA (1996) 93(16):8502–8507.
- HANAHAN D, FOLKMAN J: Patterns and emerging mechanisms of the angiogenic switch during tumori-genesis. Cell (1996) 86:353–364.
- O'REILLY MS et al.: Endostatin: an endogenous inhibi-tor of angiogenesis and tumor growth. Cell (1997) 88(2)277–285.
- O'REILLY MS et al.: Angiostatin: a novel angiogenesis in-hibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 79:315–328.
- BOEHM T et al.: Antiangiogenic therapy of experimen-tal cancer does not induce acquired drug resistance. Nature (1997) 390:404–407.
- O'REILLY MS et al.: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Merl. (1996) 2(6):689–692.
- MERENMIES J, PARADA LF, HENKEMEYER M: Receptor ty-rosine kinase signaling in vascular development. Cell Growth Differ. (1997) 8 (0 :3–10.
- DAVIS S et al.: Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression clon-ing. Cell (1996) 87(7):1161–1169.
- ENHOLM B et al.: Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene (1997) 14 (20):2475–2483.
- FOURNIER E, BIRNBAUM D, BORG JP: Receptors for fac-tors of the VEGF family. Bull. Cancer (1997) 84(4):397–403.
- TRAXLER PM: Protein tyrosine kinase inhibitors in can-cer treatment. Exp. Opin. Ther. Patents (1997) 7(6):571–588.
- WARD WHJ et al: Epidermal growth factor receptor ty-rosine kinase - Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem. Pharmacol. (1994) 48(4):659–666.
- FRY DW et al.: A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (1994) 265 (5175):1093–1095.
- WOODBURN J: AA CR Abstracts (1997).
- MOYER JD et al.: Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. (1997) 57(20:4838–4848.
- BRIDGES AJ et al: Tyrosine kinase inhibitors .8. An un-usually steep structure-activity relationship for ana-logues of 4 -(3-bromoanilino)-6,7-dimethoxy-quinazoline (PD 153035), a potent inhibitor of the epi-dermal growth factor receptor. J. Med. Chem. (1996) 39(1):267–276.
- HIRTH P: NMHCC (1997).